García Ramírez, P.; Callejas Charavia, M.; Oliva Martin, R.; Gómez La Hoz, A.M.; Ortega, M.Á.; García Suárez, J.; Álvarez-Mon, M.; Monserrat Sanz, J.
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment. Vaccines 2024, 12, 961.
https://doi.org/10.3390/vaccines12090961
AMA Style
García Ramírez P, Callejas Charavia M, Oliva Martin R, Gómez La Hoz AM, Ortega MÁ, García Suárez J, Álvarez-Mon M, Monserrat Sanz J.
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment. Vaccines. 2024; 12(9):961.
https://doi.org/10.3390/vaccines12090961
Chicago/Turabian Style
García Ramírez, Patricia, Marta Callejas Charavia, Raquel Oliva Martin, Ana María Gómez La Hoz, Miguel Ángel Ortega, Julio García Suárez, Melchor Álvarez-Mon, and Jorge Monserrat Sanz.
2024. "SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment" Vaccines 12, no. 9: 961.
https://doi.org/10.3390/vaccines12090961
APA Style
García Ramírez, P., Callejas Charavia, M., Oliva Martin, R., Gómez La Hoz, A. M., Ortega, M. Á., García Suárez, J., Álvarez-Mon, M., & Monserrat Sanz, J.
(2024). SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment. Vaccines, 12(9), 961.
https://doi.org/10.3390/vaccines12090961